Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OSHIRO, L. S.
Right arrow Articles by LENNETTE, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OSHIRO, L. S.
Right arrow Articles by LENNETTE, E. H.
NEUROLOGY 1976;26:57
© 1976 American Academy of Neurology

Viruslike particles in muscle from a patient with amyotrophic lateral sclerosis

LYNDON S. OSHIRO, Ph.D., NATALIE E. CREMER, Ph.D., FORBES H. NORRIS, JR., M.D. and EDWIN H. LENNETTE, M.D., Ph.D.

From the Viral and Rickettsial Disease Laboratory, California State Department of Health, Berkeley (Drs. Oshiro, Cremer, and Lennette), and the Institutes of Medical Sciences, San Francisco (Dr. Norris).

An electron microscopic study of muscle and central nervous tissues from a case of amyotrophic lateral sclerosis showed crystalline arrays of 20 to 24 nm viruslike particles in muscle. The particles were located between the myofibrils, adjacent to the Z bands, and near the perinuclear region, but were never seen within the nucleus. Cell cultures from the same muscle specimens showed no such particles. Central nervous system tissues and cultures also failed to show viruslike particles. The cultures were negative by the indirect fluorescent antibody technique with serums from patients with amyotrophic lateral sclerosis. The nature of these particles or their relationship to amyotrophic lateral sclerosis is unknown.

Dr. Lennette's address is Biomedical Laboratories, State of California-Department of Health, 2151 Berkeley Way, Berkeley, CA 94704.

This investigation was supported by Public Health Service grants AI08200 and AI-01475 from the National Institute of Allergy and Infectious Diseases, National institutes of Health, and a grant from the C. E. Merrill Trust.

Received for publication March 26, 1975.




This article has been cited by other articles:


Home page
NeurologyHome page
E. Beghi, A. Chio, M. Inghilleri, L. Mazzini, A. Micheli, G. Mora, M. Poloni, R. Riva, L. Serlenga, D. Testa, et al.
A randomized controlled trial of recombinant interferon beta-1a in ALS
Neurology, January 25, 2000; 54(2): 469 - 469.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.